Oramed Pharmaceuticals Long-Term Investments 2011-2024 | ORMP

Oramed Pharmaceuticals long-term investments from 2011 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.

Oramed Pharmaceuticals Long-Term Investments 2011-2024 | ORMP

Oramed Pharmaceuticals long-term investments from 2011 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$204.2B
Stryker (SYK)$146.7B
Boston Scientific (BSX)$132.6B
EssilorLuxottica (ESLOY)$112.1B
Medtronic (MDT)$110.6B
Haleon (HLN)$43.7B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.7B
ResMed (RMD)$35.8B
Terumo (TRUMY)$29.7B
Koninklijke Philips (PHG)$24.8B
Zimmer Biomet Holdings (ZBH)$21.9B
Insulet (PODD)$18.4B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.1B
BellRing Brands (BRBR)$10.2B
Bio-Rad Laboratories (BIO)$9.3B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.5B
Haemonetics (HAE)$4.3B
Prestige Consumer Healthcare (PBH)$4.2B
ICU Medical (ICUI)$4.1B
Perrigo (PRGO)$3.8B
Envista Holdings (NVST)$3.7B
Neogen (NEOG)$3.2B
Agios Pharmaceuticals (AGIO)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.8B
QuidelOrtho (QDEL)$2.7B